mTOR referees memory and disease through mRNA repression and competition

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Mammalian target of rapamycin (mTOR) is crucial for memory formation and synaptic plasticity.
• mTOR signaling is frequently dysregulated in various neurological and neurodegenerative diseases.
• Recent findings indicate mTOR's dual role in regulating protein synthesis, including repression of specific messenger RNAs (mRNAs).

Purpose of the Study:

• To explore the role of repressed mRNAs as potential negative constraints on memory formation.
• To elucidate how mTOR activity influences mRNA translation, RNA-binding proteins, and mRNA stability at the synapse.
• To discuss the implications of mTOR-mediated mRNA repression in memory processes and neurodegenerative disorders.

Main Methods:

• Review of existing literature on mTOR signaling, mRNA regulation, and memory.
• Analysis of studies investigating the relationship between mTOR activity and protein synthesis/repression.
• Discussion of the role of RNA-binding proteins and mRNA stability in synaptic function.

Main Results:

• mTOR activation can repress the translation of specific mRNAs, potentially acting as negative regulators of memory.
• mTOR influences synaptic protein expression through regulation of RNA-binding proteins and mRNA stability.
• Dysregulated mTOR activity and aberrant mRNA repression are implicated in memory deficits.

Conclusions:

• Repressed mRNAs coding for memory suppressors may represent the negative constraints hypothesized to limit memory formation.
• Understanding mTOR's regulation of mRNA translation and stability is key to deciphering memory mechanisms.
• Targeting mTOR-mediated mRNA repression pathways could offer therapeutic strategies for memory and neurodegenerative diseases.